In vivo imaging of zebrafish retinal cells using fluorescent coumarin derivatives
- Kohei Watanabe†1, 6,
- Yuhei Nishimura†1, 2, 3, 4,
- Takehiko Oka1,
- Tsuyoshi Nomoto6,
- Tetsuo Kon1,
- Taichi Shintou6,
- Minoru Hirano1,
- Yasuhito Shimada1, 2, 3, 4,
- Noriko Umemoto1,
- Junya Kuroyanagi1,
- Zhipeng Wang1,
- Zi Zhang1,
- Norihiro Nishimura2, 5,
- Takeshi Miyazaki6,
- Takeshi Imamura6 and
- Toshio Tanaka1, 2, 3, 4Email author
© Watanabe et al; licensee BioMed Central Ltd. 2010
Received: 16 April 2010
Accepted: 15 September 2010
Published: 15 September 2010
The zebrafish visual system is a good research model because the zebrafish retina is very similar to that of humans in terms of the morphologies and functions. Studies of the retina have been facilitated by improvements in imaging techniques. In vitro techniques such as immunohistochemistry and in vivo imaging using transgenic zebrafish have been proven useful for visualizing specific subtypes of retinal cells. In contrast, in vivo imaging using organic fluorescent molecules such as fluorescent sphingolipids allows non-invasive staining and visualization of retinal cells en masse. However, these fluorescent molecules also localize to the interstitial fluid and stain whole larvae.
We screened fluorescent coumarin derivatives that might preferentially stain neuronal cells including retinal cells. We identified four coumarin derivatives that could be used for in vivo imaging of zebrafish retinal cells. The retinas of living zebrafish could be stained by simply immersing larvae in water containing 1 μg/ml of a coumarin derivative for 30 min. By using confocal laser scanning microscopy, the lamination of the zebrafish retina was clearly visualized. Using these coumarin derivatives, we were able to assess the development of the zebrafish retina and the morphological abnormalities induced by genetic or chemical interventions. The coumarin derivatives were also suitable for counter-staining of transgenic zebrafish expressing fluorescent proteins in specific subtypes of retinal cells.
The coumarin derivatives identified in this study can stain zebrafish retinal cells in a relatively short time and at low concentrations, making them suitable for in vivo imaging of the zebrafish retina. Therefore, they will be useful tools in genetic and chemical screenings using zebrafish to identify genes and chemicals that may have crucial functions in the retina.
The similarities in the morphologies and functions of the zebrafish and human retinas have made the zebrafish visual system a useful research model [1–4]. Like the human retina, the neuronal cell bodies are precisely organized in three major laminae, the ganglion cell layer (GCL), inner nuclear layer (INL) and outer nuclear layer (ONL) . These three laminae are separated by plexiform layers, the inner plexiform layer (IPL) and outer plexiform layer (OPL), which mainly contain neuronal projections . Furthermore, the zebrafish has a cone-dense retina and thus has rich color vision, providing an advantage over nocturnal rodent retina studies [2, 3]. The organization of the genome and the genetic pathways controlling signal transduction and retinal development are also highly conserved between zebrafish and humans . Because zebrafish are highly tractable to both genetic and chemical manipulation, many genetic and chemical screenings have been performed [1–7]. From these screenings, a number of genes and chemicals have been identified that could affect the structures and functions of the vertebrate retina [1–5].
Retinal research has been facilitated by improvements in imaging techniques. Multiple technical developments have permitted the visualization of retinal cell structures and their dynamics in vitro, ex vivo and in vivo. In vitro approaches such as immunohistochemical analyses allow the labeling of certain retinal cell types . DiOlistic labeling with fluorescent dyes is an ex vivo approach to display arbor morphologies of the retina by labeling single cells discretely . These in vitro and ex vivo approaches can be used with multiple probes to detect changes in several retinal cell types simultaneously [9, 10]. However, these approaches are labor-intensive and have relatively low throughputs. As an in vivo approach, stable transgenic zebrafish lines expressing fluorescent proteins such as green fluorescent protein (GFP) have been used [11, 12]. In these transgenic lines, fluorescent proteins are expressed in specific cell types, such as rod photoreceptors , UV-sensitive cone photoreceptors , subtypes of bipolar cells  and retinal ganglion cells (RGC) [11, 12]. Although these transgenic lines can be used for high-throughput in vivo screening by assessing the changes in the fluorescent signals in the retina [11, 12], the assessments are usually restricted to the cells expressing the fluorescent proteins.
Another technique for in vivo imaging is vital staining of the zebrafish retina using fluorescent small molecules [16, 17]. Zebrafish larvae absorb small molecules present in the surrounding water through their skin and gills . Fluorescent sphingolipids such as Bodipy-ceramide have been used as labeling agents for in vivo imaging of the zebrafish retina [19, 20]. Fluorescent sphingolipids are inserted into the plasma membrane of many cells in zebrafish, allowing the cellular and axon layers of the zebrafish retina to be visualized . However, since fluorescent sphingolipids also localize to the interstitial fluid of zebrafish larvae, the whole larvae are stained en masse. Therefore, in vivo imaging of the zebrafish retina using fluorescent sphingolipids requires staining for several hours and at high concentrations (50-100 μM) to achieve visualization.
In this study, we screened fluorescent coumarin derivatives that could resolve these problems. It has been shown that coumarin derivatives can reach the mammalian brain by passing through the blood-brain barrier (BBB) and have potential as therapeutic agents for autoimmune encephalomyelitis  and amyloid imaging agents for Alzheimer's disease . Since the BBB and blood-retinal barrier (BRB) are both endothelial barriers where tight junctions between the endothelial cells seal the vascular lumen , we hypothesized that coumarin derivatives would also be delivered into the retina. This screening identified four coumarin derivatives that are suitable for in vivo imaging of the zebrafish retina.
Identification of coumarin derivatives suitable for in vivo imaging of the zebrafish retina
Coumarin derivatives used in this study
The coumarin derivatives are fixable
Staining of rod and UV-sensitive cone photoreceptor cells
Next, we utilized a transgenic zebrafish line, Tg (sws1:GFP), that selectively expresses GFP in UV-sensitive cone photoreceptors under the control of the sws1 promoter . sws1 encodes the opsin protein, which is selectively expressed in zebrafish UV-sensitive cone photoreceptor cells . Retinal sections from Tg (sws1:GFP) were counter-stained with DIBPBC whose fluorescence spectrum can be distinguished from that of GFP. As shown in Figure 3G and 3H, the fluorescent signals of DIBPBC partly overlapped with GFP signals of Tg (sws1:GFP) at both the outer segments and pedicles of UV-sensitive cones, suggesting that DIBPBC can also stain UV-sensitive cone photoreceptors.
In vivo imaging of retinal development in zebrafish
We also used DIBPBC to stain the transgenic zebrafish lines Tg (rh:GFP), which selectively expresses GFP in rod photoreceptors under the control of the rh promoter , and Tg (huc:Kaede) , which selectively expresses the fluorescent protein Kaede in RGC and amacrine cells under the control of the huc promoter . The results are shown in Additional file 1: Figure S1 and Additional file 2: Figure S2. At 1 dpf, neither GFP nor Kaede was detected in the retina. At 2 dpf, GFP was detected in a patch of the ventronasal retina and Kaede was detected in RGC inside the IPL. At 3 dpf, the GFP signals increased in the ventronasal patch and Kaede was detected in both RGC and amacrine cells outside of the IPL. At 4 dpf, GFP signals were scattered outside the ventral region. At 5 dpf, the GFP signals outside the ventral region increased further. At all stages, DIBPBC visualized all of the retinas and served as an excellent counter-stain for GFP- and Kaede-expressing retinal cells.
In vivo imaging of the neuronal disorganization of the zebrafish retina in a genetic model of retinopathy
To examine the feasibility of using coumarin derivatives to visualize the morphological abnormalities in retinal diseases, we used a known genetic zebrafish model of retinopathy, crb2a morphant. crb2a, which encodes crumbs homolog 2 protein, is the causative gene of the oko meduzy mutant . The oko meduzy mutation or knockdown of crb2a causes striking disorganization of the zebrafish retina .
In vivo imaging of the neuronal disorganization of the zebrafish retina induced by chemical intervention
Structural characterization of the coumarin derivatives suitable for in vivo imaging of the zebrafish retina
In this study, we were able to distinguish among coumarin derivatives based on their abilities to stain the zebrafish retina. The fluorescence intensities of the coumarin derivatives measured in DMSO were similar (Table 1), suggesting that the differences in the staining abilities may reflect differences in their interactions with target biomolecules in the zebrafish retina and/or their affinities for transporters located at the BRB. We demonstrated that BIDEC, BIC and BIDPC possessing a benzimidazole functional moiety showed comparatively weak staining abilities. According to a previous study , the carbonyl group in the coumarin moiety can form complexes with other molecules. The oxygen atom of the carbonyl group in the coumarin moiety and either the sulfur atom in benzothiazole (BTDEC) or the oxygen atom in benzoxazole (BODEC and MBODEC) seem to coordinate with biomolecules by forming a stable intermolecular six-membered ring state. On the other hand, for BIDEC, BIC and BIDPC, the oxygen atom of the carbonyl group in the coumarin moiety and the hydrogen-bonded nitrogen atom in benzimidazole seem to form a stable intra-molecular six-membered ring state. The differences in the interactions with target biomolecules in the zebrafish retina may cause the differences in the staining abilities of the coumarin derivatives. The structural differences among the coumarin derivatives may also result in different permeabilities through the BRB. Previous studies have shown that the permeability of fluorescein through the BRB remains low because active efflux transporters pump out the molecules [34, 35]. If the coumarin derivatives with a benzimidazole moiety (i.e. BIDEC, BIC and BIDPC) tend to be ligands for the efflux transporters in the BRB, their staining abilities of the retina may be low. Further studies are required to elucidate the structure-staining relationships.
Comparison of fluorescent small molecules for vital staining of the zebrafish retina
Bodipy-ceramide and inorganic nanocrystal fluorophores such as quantum dots (QD) have been used for in vivo imaging of the zebrafish retina [16, 17]. The coumarin derivatives identified in this study differ from these fluorescent molecules in several aspects. First, the coumarin derivatives preferentially distribute to neuronal tissues including retinal cells and brain in zebrafish larvae, suggesting that the coumarin derivatives can penetrate both BRB and BBB. The mechanism is currently unknown. Bodipy-ceramide not only stains the plasma membranes of all cells in zebrafish larvae but also localizes to the interstitial fluid . Although the intracellular distribution of QD in zebrafish larvae is dependent on the QD coating , we could not find any reports showing selective tissue distribution of QD. Therefore, the preferential neuronal distribution of coumarin derivatives is a significant feature. Second, the vital staining using the coumarin derivatives is fast and cheap. The in vivo imaging using coumarin derivatives requires 30 min of staining at 1 μg/ml (about 3 μM), whereas the in vivo imaging using Bodipy-ceramide requires 2-8 hours of staining at 50-100 μM [19, 20]. These differences suggest that the fluorescence intensities of the coumarin derivatives in the retina may be stronger than that of Bodipy-ceramide owing to preferential accumulation of the coumarin derivatives in the neuronal tissues. Third, the fluorescence spectra of the coumarin derivatives are well separated from those of GFP and red fluorescent protein, making it possible to counter-stain transgenic zebrafish. The fluorescence spectrum of QD can be controlled by the constituent materials, particle size and surface chemistry , making QD suitable for counter-staining of transgenic zebrafish expressing fluorescent proteins . However, QD cannot be absorbed into zebrafish larvae and require intra-retinal injection of the QD. These features render the coumarin derivatives well-balanced labeling agents for in vivo imaging of the zebrafish retina and powerful tools for genetic and chemical screenings using the zebrafish retina.
Potential of the coumarin derivatives for in vivo imaging of mammalian retinas
Although rodents are nocturnal animals with poor color vision, they have been standard laboratory models for retinal research . The current methods for in vivo imaging of rodent retinas often require either retrograde or intravitreal injection of fluorescent probes such as cyanine dyes to visualize RGC . These injections are invasive and may require the administration of probes to be repeated for long-term assessment . It would be very valuable if the less invasive administration of the coumarin derivatives identified in this study would also be able to stain rodent retinas. The preliminary experiments using mouse suggest that the coumarin derivatives intravenously injected can penetrate the BRB and stain multiple layers of the mouse retina (data not shown). Further studies are required to examine whether the coumarin derivatives can be used for in vivo imaging of the rodent retina.
In this study, we have identified coumarin derivatives that can preferentially stain retinal cells, thereby enabling visualization of the multiple layers in the retina in living zebrafish. These coumarin derivatives can be applied to genetic and chemical screenings using zebrafish to identify genes and chemicals that may affect retinal development and the pathogenesis of retinal diseases. The structural characterization of the coumarin derivatives may also provide useful information to identify chemicals that can accumulate in retinal cells.
Zebrafish were bred and maintained according to the methods described by Westerfield . Briefly, zebrafish were raised on 14-h/10-h light/dark cycle at 28.5 ± 0.5°C. Embryos were obtained via natural mating and cultured in egg water. All experiments in this study were carried out according to the ethical guidelines established by the Institutional Animal Care and Use Committee at Mie University. Embryos older than 24 hours post-fertilization (hpf) were treated with 200 μM 1-phenyl-2-thiourea (PTU) to block pigmentation. Transgenic zebrafish lines expressing GFP under the control of the sws1 and rh promoters and Kaede under the control of the huc promoter were obtained from the National BioResource Project for Zebrafish (http://www.shigen.nig.ac.jp/zebra/index_en.html).
All the fluorescent coumarin derivatives (BODEC, MBODEC, BTDEC, DIBPBC, BIDEC, BIC, BIDPC and DOBPBC) examined were obtained from Canon Inc. (Tokyo, Japan). Stock solutions of the coumarin derivatives were prepared by dissolution in DMSO at 1 mg/ml. Mebendazole was purchased from Sigma-Aldrich (St. Louis, MO). BBC was obtained from Namiki Shoji Co. Ltd. (Tokyo, Japan).
In vivo imaging of the zebrafish retina
Zebrafish larvae were exposed by immersion in egg water containing 1 μg/ml of a coumarin derivative for 30 min at 28.5 ± 0.5°C. After a brief wash with egg water, the larvae were anesthetized with 0.016% tricaine methanesulfonate (MS-222) and transferred onto glass slides. A few drops of 2% low-melting agarose containing 0.016% MS-222 were laid over the larvae and the larvae were immediately oriented on the lateral side. The retinas of the embedded larvae were observed using a Zeiss 510 confocal laser scanning microscope. Images were captured at a resolution of 512×512 pixels using a 20× (NA 0.75) or 40× (NA 1.2) water immersion objective lens. The images were processed with Image J (http://rsbweb.nih.gov/ij/index.html).
Zebrafish were fixed in Histo-Fresh (Falma, Tokyo, Japan) at 4°C overnight. The larvae were then immersed in 30% sucrose solution at room temperature (RT) for 5 hours, and mounted in 100% Tissue-Tek OCT (Sakura Finetechnical, Tokyo, Japan) for 1 hour at RT. The retinas of adult zebrafish were mounted in 100% Tissue-Mount (Sakura Finetechnical) at 4°C overnight. These zebrafish were frozen using liquid nitrogen and isopentane and sectioned using a microtome (Leica, Tokyo, Japan). Sections of 8 μm in thickness were adhered to MAS-coated glass slides (Matsunami Glass, Osaka, Japan), dried at RT for 30 min and stored at -80°C until use. For immunofluorescence labeling, the sections were incubated at RT for 30 min, dried and washed with phosphate-buffered saline (PBS). The sections were then blocked for 1 h in a blocking solution (Nakalai Tesque, Kyoto, Japan). The blocking solution was replaced with a primary antibody diluted with Can Get Signal Solution A (Toyobo, Osaka, Japan) and incubated overnight at 4°C. The sections were washed three times with PBS containing 0.2% Triton X-100 (PBS-T), followed by incubation for 1 h at RT with fluorescent secondary antibodies (Invitrogen) diluted with Can Get Signal Solution A. A coumarin compound (1 μg/ml of BODEC, DIBPBC or MBODEC) was also included in the secondary antibody solution. The sections were washed three times with PBS-T, and mounted with Fluoromount G (Southern Biotech, Birmingham, AL). The immunolocalized antigens were visualized using a Zeiss 510 confocal laser scanning microscope. The following antibodies were used: zpr3 (1:10; Zebrafish International Resource Center, Eugene, OR); anti-mouse IgG conjugated with Alexa 488 for co-staining with BODEC and MBODEC or Alexa 543 for co-staining with DIBPBC (1:100 each; Invitrogen, Carlsbad, CA).
Zebrafish embryos at the one-to-four cell stage were microinjected with an antisense morpholino for crb2a. The embryos were raised until 4 and 5 dpf in embryo water containing 200 μM PTU and subjected to the in vivo imaging.
We are grateful to the National BioResource Project of Zebrafish, Core Institution, for providing the Tg (sws1:GFP), Tg (rh:GFP) and Tg (huc:Kaede) lines and the Zebrafish International Resource Center for providing the zpr3 antibody. We would like to thank K. Nishiguchi, C. Suzuki, Y. Yoshikawa, T. Murata and A. Kamakura for experimental assistance and R. Ikeyama and Y. Yoshida for secretarial assistance. This work was partly supported by the New Energy and Industrial Technology Development Organization, Long-range Research Initiative of the Japan Chemical Industrial Association and Mie University (COE-B).
- Malicki J: Harnessing the power of forward genetics--analysis of neuronal diversity and patterning in the zebrafish retina. Trends Neurosci. 2000, 23 (11): 531-541. 10.1016/S0166-2236(00)01655-6.View ArticlePubMed
- Goldsmith P, Harris WA: The zebrafish as a tool for understanding the biology of visual disorders. Semin Cell Dev Biol. 2003, 14 (1): 11-18. 10.1016/S1084-9521(02)00167-2.View ArticlePubMed
- Fadool JM, Dowling JE: Zebrafish: a model system for the study of eye genetics. Prog Retin Eye Res. 2008, 27 (1): 89-110. 10.1016/j.preteyeres.2007.08.002.PubMed CentralView ArticlePubMed
- Richards FM, Alderton WK, Kimber GM, Liu Z, Strang I, Redfern WS, Valentin JP, Winter MJ, Hutchinson TH: Validation of the use of zebrafish larvae in visual safety assessment. J Pharmacol Toxicol Methods. 2008, 58 (1): 50-58. 10.1016/j.vascn.2008.04.002.View ArticlePubMed
- Kitambi SS, McCulloch KJ, Peterson RT, Malicki JJ: Small molecule screen for compounds that affect vascular development in the zebrafish retina. Mech Dev. 2009, 126 (5-6): 464-477. 10.1016/j.mod.2009.01.002.PubMed CentralView ArticlePubMed
- Tanaka T, Oka T, Shimada Y, Umemoto N, Kuroyanagi J, Sakamoto C, Zang L, Wang Z, Nishimura Y: Pharmacogenomics of cardiovascular pharmacology: pharmacogenomic network of cardiovascular disease models. J Pharmacol Sci. 2008, 107 (1): 8-14. 10.1254/jphs.08R03FM.View ArticlePubMed
- Wang Z, Nishimura Y, Shimada Y, Umemoto N, Hirano M, Zang L, Oka T, Sakamoto C, Kuroyanagi J, Tanaka T: Zebrafish beta-adrenergic receptor mRNA expression and control of pigmentation. Gene. 2009, 446 (1): 18-27. 10.1016/j.gene.2009.06.005.View ArticlePubMed
- Morgan J, Huckfeldt R, Wong RO: Imaging techniques in retinal research. Exp Eye Res. 2005, 80 (3): 297-306. 10.1016/j.exer.2004.12.010.View ArticlePubMed
- Yazulla S, Studholme KM: Neurochemical anatomy of the zebrafish retina as determined by immunocytochemistry. J Neurocytol. 2001, 30 (7): 551-592. 10.1023/A:1016512617484.View ArticlePubMed
- Connaughton VP, Graham D, Nelson R: Identification and morphological classification of horizontal, bipolar, and amacrine cells within the zebrafish retina. J Comp Neurol. 2004, 477 (4): 371-385. 10.1002/cne.20261.View ArticlePubMed
- Xiao T, Roeser T, Staub W, Baier H: A GFP-based genetic screen reveals mutations that disrupt the architecture of the zebrafish retinotectal projection. Development. 2005, 132 (13): 2955-2967. 10.1242/dev.01861.View ArticlePubMed
- Mumm JS, Williams PR, Godinho L, Koerber A, Pittman AJ, Roeser T, Chien CB, Baier H, Wong RO: In vivo imaging reveals dendritic targeting of laminated afferents by zebrafish retinal ganglion cells. Neuron. 2006, 52 (4): 609-621. 10.1016/j.neuron.2006.10.004.PubMed CentralView ArticlePubMed
- Hamaoka T, Takechi M, Chinen A, Nishiwaki Y, Kawamura S: Visualization of rod photoreceptor development using GFP-transgenic zebrafish. Genesis. 2002, 34 (3): 215-220. 10.1002/gene.10155.View ArticlePubMed
- Takechi M, Hamaoka T, Kawamura S: Fluorescence visualization of ultraviolet-sensitive cone photoreceptor development in living zebrafish. FEBS Lett. 2003, 553 (1-2): 90-94. 10.1016/S0014-5793(03)00977-3.View ArticlePubMed
- Zhao XF, Ellingsen S, Fjose A: Labelling and targeted ablation of specific bipolar cell types in the zebrafish retina. BMC Neurosci. 2009, 10: 107-10.1186/1471-2202-10-107.PubMed CentralView ArticlePubMed
- Cooper MS, D'Amico LA, Henry CA: Confocal microscopic analysis of morphogenetic movements. Methods Cell Biol. 1999, 59: 179-204. full_text.View ArticlePubMed
- Rieger S, Kulkarni RP, Darcy D, Fraser SE, Koster RW: Quantum dots are powerful multipurpose vital labeling agents in zebrafish embryos. Dev Dyn. 2005, 234 (3): 670-681. 10.1002/dvdy.20524.View ArticlePubMed
- McGrath P, Li CQ: Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today. 2008, 13 (9-10): 394-401. 10.1016/j.drudis.2008.03.002.View ArticlePubMed
- Das T, Payer B, Cayouette M, Harris WA: In vivo time-lapse imaging of cell divisions during neurogenesis in the developing zebrafish retina. Neuron. 2003, 37 (4): 597-609. 10.1016/S0896-6273(03)00066-7.View ArticlePubMed
- Liu IH, Zhang C, Kim MJ, Cole GJ: Retina development in zebrafish requires the heparan sulfate proteoglycan agrin. Dev Neurobiol. 2008, 68 (7): 877-898. 10.1002/dneu.20625.View ArticlePubMed
- Chen X, Pi R, Zou Y, Liu M, Ma X, Jiang Y, Mao X, Hu X: Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin. Eur J Pharmacol. 2010, 629 (1-3): 40-46. 10.1016/j.ejphar.2009.12.008.View ArticlePubMed
- Kudo K, Suzuki M, Suemoto T, Okamuta N, Shiomitsu T, Shimazu H: Japan Patent Kokai 2004-250411. 2004
- Mannermaa E, Vellonen KS, Urtti A: Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev. 2006, 58 (11): 1136-1163. 10.1016/j.addr.2006.07.024.View ArticlePubMed
- Cooper MS, Szeto DP, Sommers-Herivel G, Topczewski J, Solnica-Krezel L, Kang HC, Johnson I, Kimelman D: Visualizing morphogenesis in transgenic zebrafish embryos using BODIPY TR methyl ester dye as a vital counterstain for GFP. Dev Dyn. 2005, 232 (2): 359-368. 10.1002/dvdy.20252.View ArticlePubMed
- Gulati-Leekha A, Goldman D: A reporter-assisted mutagenesis screen using alpha 1-tubulin-GFP transgenic zebrafish uncovers missteps during neuronal development and axonogenesis. Dev Biol. 2006, 296 (1): 29-47. 10.1016/j.ydbio.2006.03.024.View ArticlePubMed
- Chinen A, Hamaoka T, Yamada Y, Kawamura S: Gene duplication and spectral diversification of cone visual pigments of zebrafish. Genetics. 2003, 163 (2): 663-675.PubMed CentralPubMed
- Schmitt EA, Dowling JE: Early retinal development in the zebrafish, Danio rerio: light and electron microscopic analyses. J Comp Neurol. 1999, 404 (4): 515-536. 10.1002/(SICI)1096-9861(19990222)404:4<515::AID-CNE8>3.0.CO;2-A.View ArticlePubMed
- Hu M, Easter SS: Retinal neurogenesis: the formation of the initial central patch of postmitotic cells. Dev Biol. 1999, 207 (2): 309-321. 10.1006/dbio.1998.9031.View ArticlePubMed
- Sato T, Takahoko M, Okamoto H: HuC:Kaede, a useful tool to label neural morphologies in networks in vivo. Genesis. 2006, 44 (3): 136-142. 10.1002/gene.20196.View ArticlePubMed
- Ekstrom P, Johansson K: Differentiation of ganglion cells and amacrine cells in the rat retina: correlation with expression of HuC/D and GAP-43 proteins. Brain Res Dev Brain Res. 2003, 145 (1): 1-8. 10.1016/S0165-3806(03)00170-6.View ArticlePubMed
- Omori Y, Malicki J: oko meduzy and related crumbs genes are determinants of apical cell features in the vertebrate embryo. Curr Biol. 2006, 16 (10): 945-957. 10.1016/j.cub.2006.03.058.View ArticlePubMed
- Santaella RM, Fraunfelder FW: Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007, 67 (1): 75-93. 10.2165/00003495-200767010-00006.View ArticlePubMed
- Suzuki Y, Komatsu H, Ikeda T, Saito N, Araki S, Citterio D, Hisamoto D, Kitamura Y, Kubota T, Nakagawa J, et al.: Design and synthesis of Mg2+-selective fluoroionophores based on a coumarin derivative and application for Mg2+ measurement in a living cell. Anal Chem. 2002, 74 (6): 1423-1428. 10.1021/ac010914j.View ArticlePubMed
- Koyano S, Araie M, Eguchi S: Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid. Invest Ophthalmol Vis Sci. 1993, 34 (3): 531-538.PubMed
- Engler CB, Sander B, Larsen M, Koefoed P, Parving HH, Lund-Andersen H: Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier. Acta Ophthalmol (Copenh). 1994, 72 (6): 663-667. 10.1111/j.1755-3768.1994.tb04676.x.View Article
- Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R, Nann T: Quantum dots versus organic dyes as fluorescent labels. Nat Methods. 2008, 5 (9): 763-775. 10.1038/nmeth.1248.View ArticlePubMed
- Leung CK, Lindsey JD, Crowston JG, Ju WK, Liu Q, Bartsch DU, Weinreb RN: In vivo imaging of murine retinal ganglion cells. J Neurosci Methods. 2008, 168 (2): 475-478. 10.1016/j.jneumeth.2007.10.018.View ArticlePubMed
- Westerfield M: The Zebrafish Book. A guide for the laboratory use of zebrafish (Danio rerio). 2007
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.